```

[Federal Register Volume 74, Number 181 (Monday, September 21, 2009)]
[Notices]
[Pages 48104-48105]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-22599]

-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION

Advisory Committee on the Medical Uses of Isotopes: Meeting 
Notice

AGENCY: U.S. Nuclear Regulatory Commission.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: NRC will convene a meeting of the Advisory Committee on the 
Medical Uses of Isotopes (ACMUI) on October 19-20, 2009. A sample of 
agenda items to be discussed during the public session includes: (1) 
International Commission on Radiological Protection (ICRP) 
Publication103 subcommittee report and discussion; (2) update on 
permanent prostate brachytherapy medical events; (3) update on results 
from the Society of Nuclear Medicine

[[Page 48105]]

(SNM) on the medical isotope shortage; (4) new security regulations in 
10 Code of Federal Regulations (CFR) part 37; (5) potential changes to 
10 CFR part 35; (6) medical uses of radium-223; (7) information on the 
regulatory responsibilities of the U.S. Food and Drug Administration; 
(8) summary of the enforcement process and enforcement actions against 
medical licensees; and (9) medical-related events. A copy of the agenda 
will be available at http://www.nrc.gov/reading-rm/doc-collections/acmui/agenda or by e-mailing Ms. Ashley Cockerham at the contact 
information below.
    Purpose: Discuss issues related to 10 CFR part 35 Medical Use of 
Byproduct Material.
    Date and Time for Closed Session: October 19, 2009, from 8 a.m. to 
10 a.m. This session will be closed so that ACMUI can review and 
discuss evaluations, receive annual training, and discuss internal 
Committee business.
    Date and Time for Open Sessions: October 19, 2009, from 10:15 a.m. 
to 4:45 p.m. and October 20, 2009, from 8 a.m. to 12 p.m.
    Address for Public Meeting: U.S. Nuclear Regulatory Commission, 
Executive Boulevard Building (EBB01-B13/15), 6003 Executive Boulevard, 
Rockville, Maryland 20852.
    Public Participation: Any member of the public who wishes to 
participate in the meeting should contact Ms. Cockerham using the 
information below.
    Contact Information: Ashley M. Cockerham, e-mail: 
[email protected], telephone: (240) 888-7129.

Conduct of the Meeting

    Leon S. Malmud, M.D., will chair the meeting. Dr. Malmud will 
conduct the meeting in a manner that will facilitate the orderly 
conduct of business. The following procedures apply to public 
participation in the meeting:
    1. Persons who wish to provide a written statement should submit an 
electronic copy to Ms. Cockerham at the contact information listed 
above. All submittals must be received by October 9, 2009, and must 
pertain to the topic on the agenda for the meeting.
    2. Questions and comments from members of the public will be 
permitted during the meeting, at the discretion of the Chairman.
    3. The draft transcript will be available on ACMUI's Web site 
(http://www.nrc.gov/reading-rm/doc-collections/acmui/tr/) on or about 
November 23, 2009. A meeting summary will be available on ACMUI's Web 
site (http://www.nrc.gov/reading-rm/doc-collections/acmui/meeting-summaries/) on or about December 2, 2009.
    4. Persons who require special services, such as those for the 
hearing impaired, should notify Ms. Cockerham of their planned 
attendance.
    This meeting will be held in accordance with the Atomic Energy Act 
of 1954, as amended (primarily section 161a); the Federal Advisory 
Committee Act (5 U.S.C. App); and the Commission's regulations in Title 
10, U.S. Code of Federal Regulations, part 7.

    Dated: September 16, 2009.
Andrew L. Bates,
Advisory Committee Management Officer.
[FR Doc. E9-22599 Filed 9-18-09; 8:45 am]
BILLING CODE 7590-01-P
```